Established human EOC cell lines |
|
√ Availability of cell lines |
√ Cell alteration due to high number of passages |
√ Large number of cell lines with various genetic backgrounds |
√ Not suitable for immunological studies |
√ Easy maintenance |
|
√ Cells can be genetically manipulated |
|
√ Low cost |
|
Established mouse EOC cell lines |
|
√ Availability of cell lines |
√ Cell alteration due to high number of passages |
√ Suitable for immunological studies |
|
√ Easy maintenance |
|
√ Cells can be genetically manipulated |
|
√ Low cost |
|
Patient-derived xenografts |
|
√ PDX derived from EOC patients, not altered by in vitro culture
|
√ Slow tumor growth |
√ Recapitulates EOC tumor microenvironment |
√ Difficult maintenance |
|
√ Specialized training required |
|
√ Limited access to tumor samples |
|
√ PDXs cannot be genetically manipulated |